Notice

Center for Scientific Review; Amended Notice of Meeting

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Health and Human Services Department, National Institutes of Health. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

No specific effective date is indicated. Check the full text for date provisions.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number	2025-19026
Type	Notice
Published	Sep 30, 2025
Effective Date	-
RIN	-
Docket ID	-
Text Fetched	Yes

Agencies & CFR References

Agency Hierarchy:

Health and Human Services Department→National Institutes of Health

CFR References:

None

Linked CFR Parts

Part	Name	Agency
No linked CFR parts

Paired Documents

Type	Proposed	Final	Method	Conf
No paired documents

External Links

View on FederalRegister.gov Search Regulations.gov

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

Incorporate requirements by reference (IBR) to external documents
Are procedural notices without substantive obligations
Contain only preamble/explanation without regulatory text

▼ Full Document Text (144 words · ~1 min read)

Text Preserved

<NOTICE>
 
 DEPARTMENT OF HEALTH AND HUMAN SERVICES 
 <SUBAGY>National Institutes of Health</SUBAGY>
 <SUBJECT>Center for Scientific Review; Amended Notice of Meeting</SUBJECT>
 
 Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, RFA-AI-24-080 Broad Spectrum Products Against Multiple Neurotoxin Botulinum Serotypes (R61/R33 Clinical Trial Not Allowed). November 14, 2025, 10:00 a.m. to November 14, 2025, 05:00 p.m., National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the 
 <E T="04">Federal Register</E>
 on September 23, 2025, 90 FR 45775, Doc No. 2025-18347
 
 This meeting is being amended to change the date from November 14, 2025, to December 2, 2025. The meeting is closed to the public. 
 <SIG>
 <DATED> Dated: September 26, 2025.</DATED>
 <NAME>Denise M. Santeufemio, </NAME>
 Program Analyst, Office of Federal Advisory Committee Policy. 
 </SIG>
 
 <FRDOC>[FR Doc. 2025-19026 Filed 9-29-25; 8:45 am]</FRDOC>
 </NOTICE>
						

This text is preserved for citation and comparison. View the official version for the authoritative text.

📄 PDF 🏛️ Official Version